By Sam Schulz ( October 8, 2007, 12:00 AM EDT) -- Weeks after it sued Mylan Pharmaceuticals Inc. and a slew of other generics in a Delaware district court over the patents for prostate treatment Uroxatral, Sanofi-Aventis filed another such complaint against Mylan in West Virginia federal court on Friday, in order to avoid risking an automatic 30-month stay of approval for a generic version of its drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.